copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Omics and AI advance biomarker discovery for liver disease New technologies allow the noninvasive detection and staging of asymptomatic alcohol-associated liver disease; further refinement of this approach could transform clinical management and improve
Safety of Acamprosate in Patients With Alcohol-Associated Liver Disease . . . Methods: In this phase 2 open-label study, 12 patients with alcohol use disorder and alcohol-associated liver disease were enrolled between September 2020 and May 2022 Participants received acamprosate for 12 weeks and were followed up to 24 weeks
Tiffany Wu - AASLD Early Liver Transplantation for Severe Alcohol-Associated Hepatitis: the Keys for Selection, Prognostication and Monitoring 11:00 - 12:30 PM EST Auditorium Learn More
Tiffany Wu | Gastroenterology | Rochester, MN | MediFind Tiffany Wu is a Gastroenterologist in Rochester, Minnesota Her top areas of expertise are Alpha-1 Antitrypsin Deficiency (AATD), Liver Failure, Emphysema, and Hepatitis
The digital transformation of hepatology: The patient is logged in In this review, we discuss the unique transformation underway in the care of patients with liver disease, specifically examining the digital transformation of diagnostics, prediction and clinical decision-making, and management